CYNTHIA K. SITES, M.D.
K24 RR019705 (Sites, P.I.) NIH

Soy Phytoestrogen Supplementation & Menopause

American Heart Association (Sites, P.I.)
AHA 0355680T

Soy Phytoestrogens & Metabolic Cardiovascular Risk

UAHSF
HSF-GEF Scholar Award

RICHARD E. BLACKWELL, PH.D, M.D.
NIH
Cooperative Multicenter Reproductive Medicine Network

JOHN A. LUCAS, M.D.
HSF-GEF Clinical Care Initiative
Center for Fertility Preservation in Cancer Survivors

C. RICHARD PARKER, PH.D.
NIH Program Project: Initiation of Human Labor: Prevention of Prematurity “Project 1. Endocrine Cascades and Parturition" Co-Investigator, PI at UAB as subcontract site.

NIH "Human Cytosolic Sulfotransferases"
Co-Investigator

Southeastern Center of Excellence in Geriatric Medicine "Low Dose 17Beta Estradiol Cream: Pharmacokinetics, Local and Cellular Vaginal Response"
Co-Investigator

FACULTY – LIST OF PEER REVIEWED PUBLICATIONS DURING THE LAST THREE YEARS

RICHARD E. BLACKWELL, PH.D., M.D.
Macaluso M, Lawson ML, Hortin G, Guerr A, Hammond KR, Blackwell R, Bloom A. Efficacy of the female condom as a barrier to semen during intercourse. Amer J Epid 157(4):289-297, 2003.

Lawson ML, Macaluso M, Duerr A, Hortin G, Hammond KR, Blackwell R, Artz L, Bloom A. Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom. Am J Epid 157(4):282-288, 2003.

Raymond EG, Chen PL, Pierre-Louis B, Luoto J, Barnhart KT, Bradley L, Creinin MD, Poindexter A, Wan L, Martens M, Scheneken R, Nicholas CT, Blackwell RE. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Med Res Methodol. 4(1):23, 2004.

Raymond EG, Chen PL, Luoto, Spermide Trial Group. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial. Obstet Gynecol. 103(3):430-439, 2004.

Raymond EG, Chen PL, Condon S, Luoto J, Barnhart KT, Creinin MD, Poindexter A, Wan L, Martens M, Schenken R, Blackwell R. Acceptability of five nonoxynol-9 spermicides. Contraception. 71(6):438-442, 2005.

Blackwell, RE. Estrogen, progestin, and urinary incontinence. JAMA 294(21):2696-2697.

Blackwell RE. Estrogen plus progestin and risk of venous thrombosis. JAMA 293(11):1322-1323, 2005.

Blackwell RE. Opportunities and obstacles in adult women’s medicine. Sexuality Reproduction and Menopause 3(2):88-92, 2005.

C. RICHARD PARKER, JR., PH.D.
Dharia, S, Slane A, Jian M, Conner M, Conley AJ, Parker, CR Jr: Co-Localization of P450C17 and cytochrome b5 in androgen synthesizing tissues of the human, Biol Reprod 71:83-88, 2004.

Parker CR Jr., Chen C-CG: Steroid hormones and sexual function in premenopausal and postmenopausal women. Mental Fitness 3:40-45, 2004.

Davis LL, Weaver M, Zamrini E, Stevens A, Kang D-H, Parker, CR Jr: Biopsychological markers of distress in informal caregivers. Biological Research for Nursing 6:90-99, 2004.

Staton BA, Mixon RL, Dharia S, Brissie RM, Parker CR Jr: Is reduced cell size the mechanism for shrinkage of the adrenal zona reticularis in aging? Endocr Res, 30: 529-534, 2004.

Sirianni R, Rehman KS, Carr BR, Parker CR Jr, Rainey WE: Corticotropin releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J Clin Endocrinol Metab, 90:279-285, 2005.

Dharia S, Slane A, Jian M, Conner M, Conley AJ, Brissie RM, Parker CR Jr: Effects of aging on cytochrome b5 expression in the human adrenal gland. J Clin Endocrinol Metab, 90:4357-4361 2005.

Sirianni R, Mahew BA, Carr BR, Parker CR Jr, Rainey WE: Corticotrophin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate DHEAS production by human fetal adrenal cells. J Clin Endocrinol Metab 90:5393-5400, 2005.

ROBERT W. REBAR, M.D.
Martin V, Wenke S, Mandell K, Zoma W, Bean J, Pinney S, Liu J, Ramadan N, Rebar R: MedicalOophorectomy With and Without Estrogen Add-back Therapy In the Prevention of Migraine Headache 2003;43:309-21.

Liu JH, Kao L, Rebar RW, Muse K. Urinary â-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve. Menopause 2003;10:526-33.

Rebar RW, DeCherne AH. Assisted reproductive technology in the United States. N Engl J Med. 2004 Apr 15;350(16):1603-4.

Gass MS, Rebar RW, Cuffie-Jackson C, Cedars MI, Lobo RA. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol. Maturitas. 2004 Oct 15;49(2):140-7.

Chiang S, Geisler WM, Jackson JR, Rebar RW. Assessing the impact of a comprehensive sexually transmitted disease curriculum on learning outcomes. Am J Obstet Gynecol. 2004 Nov;191(5):1822-7.

Martin V, Wernke S, Mandell, K, Ramadan N, Bean J, Liu J, Rebar R, Zoma W, Behbehani M. Ovarian hormones and migraine headache: defining relationships and mechanisms. Headache 2006; 46;125-37.

CYNTHIA K. SITES, M.D.
Goldstein J, Sites CK, Toth MJ. Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. Fertil Steril 82:430-436, 2004.

Sites CK, L’Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind placebo-controlled trial. J Clin Endocrinol Metab 90:2701-2707, 2005.

Goodrow GJ, Gannon B, L’Hommedieu GD, Sites CK. Predictors of worsening insulin sensitivity in postmenopausal women. Am J Obstet Gynecol 194:355-361, 2006.

Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology. 2006 Feb 15;[Epub ahead of print].

Cooper BC, Sites CK, Fairhurst PA, Toth MJ. Evidence against a role for ovarian hormones in the regulation of blood flow. In press, Fertil Steril.

Toth MJ, Sites CK, Mathews DE, Casson PR. Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women. Am J Physiol Endocrinol Metab. 2006 Apr 18;[Epub ahead of print].

Toth MJ, Sites CK, Matthews DE. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy. Am J Physiol Endocrinol Metab. 2006 May 9;[Epub ahead of print].

Cooper BC, Sites CK, Casson PR, Toth MJ. Ovarian suppression with gonatropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. In press, Fertil Steril.

Cooper BC, Burger NZ, Toth MJ, Cushman M, Sites CK. Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. In press, Am J. Obstet Gynecol.

DANIEL R. CHRISTIE, M.D.
Christie DR, Cooper BC, Lyon D, Cliver SP, Sites CK. Effect of Soy Phytoestrogens on Systemic Markers of Inflammation and Adiposity in Postmenopausal Women. American Society for Reproductive Medicine Annual Meeting, New Orleans, Louisiana, October 21-26, 2006.

CYNTHIA K. SITES, M.D.
Sites CK, Cooper BC, Gastaldelli A, Arabshahi A, Ridzon S, Cliver SP. Effect of a daily supplement of soy phytoestrogens on body composition and insulin secretion in postmenopausal women. American Society for Reproductive Medicine Annual Meeting, New Orleans, LA, October 21-26, 2006.

Christie DR, Cooper BC, Lyon D, Cliver SP, Sites CK. Effect of soy phytoestrogens on systemic markers of inflammation and adiposity in postmenopausal women. American Society for Reproductive Medicine Annual Meeting, New Orleans, LA, October 21-26, 2006.

C. RICHARD PARKER, JR., PH.D.
Parker CR Jr., Hoskins K. Evaluation of Salivary Estradiol as a Possible Alternative to Serum Estradiol in Ovulation Induction. American Society for Reproductive Medicine Annual Meeting, New Orleans, Louisiana, October 21-26, 2006.